Xtant Medical - רווח נקי למניה אחת בשנים עשר החודשים האחרונים XTNT

Xtant Medical (XTNT) is currently focusing on extracting synergies from past acquisitions and expanding its clinical reach. Stable demand for spinal surgeries and advanced logistics provide the company with strong margins and consistent cash flow. This price chart reflects a market trend for the asset with an EPS of -1013.20. The brand's leadership is based on unique tissue processing patents that accelerate bone regeneration.
Xtant Medical Inc - פילוחים אנליטיים ומדדי מפתח (XTNT)

This metric is calculated as the percentage change in net income per share over a rolling twelve-month period, reflecting the actual dynamics of return on equity adjusted for inflation. By analyzing the YoY growth in net income per share over the last 12 months, an investor can see the impact of competitive pricing pressure and bio-implant reimbursement issues for Xtant Medical Holdings (XTNT) on the final profitability of the business.